Einhorn’s Greenlight Buys Chemours, Blasts Citron Short CallBy and
Report overestimates legal liability costs, Greenlight says
Hedge fund sold Macy’s stake for a loss after guidance cut
David Einhorn’s Greenlight Capital said it took a stake in Chemours Co., the titanium-dioxide pigment maker spun off from DuPont Co., denouncing a short recommendation from Andrew Left’s Citron Research that said the company had been "designed to fail."
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.